Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CNS vasculitis in a patient with MS on daclizumab monotherapy.
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
Extavia Prescribing Information
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Clinical proteomics of enervated neurons.
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate.
Pages
« first
‹ previous
…
46
47
48
49
50
51
52
53
54
…
next ›
last »